poisar

Stocks · News reference

Wall Street Analysts Update Ratings and Price Targets for Arrowhead Pharmaceuticals

Fiscal.ai

Several major financial institutions updated their outlooks for Arrowhead Pharmaceuticals on November 14, 2026, with price targets ranging from $96 to $126.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading